In his latest Forbes review, Dr. Steve Brozak examines The Code as Witness by Dr. Steven Quay and the broader questions it raises about scientific accountability, public trust, biotechnology, and future pandemic preparedness.
Read More about Dr. Steve Brozak Reviews The Code as Witness in ForbesWBB Securities President Dr. Steve Brozak examines the growing concerns surrounding the 2026 Ebola outbreak, including institutional distrust, attacks on healthcare infrastructure, delayed containment efforts, and the broader implications for global public health preparedness.
Read More about Deaths, Burned Clinics—What’s Different About Ebola’s 2026 Return? – Published in ForbesWBB Securities President Dr. Steve Brozak examines five urgent questions emerging from the WHO’s emergency Hantavirus meeting, including transmission risks, global preparedness, and the broader implications for public health systems in a post-pandemic environment.
Read More about 5 Urgent Questions After The WHO Emergency Hantavirus Meeting – Published in ForbesIn a recent Forbes article, Dr. Steve Brozak examines HHS Secretary Robert F. Kennedy Jr.’s focus on the mental health crisis and the growing concern around psychiatric overprescribing.
Read More about Our Mental Health Crisis: RFK Jr. Faces Psychiatric Over-Prescribing – Published in Forbes
WBB Securities President Dr. Steve Brozak moderated a panel at Biotech Showcase 2026 focused on ARPA-H and the role of federal investment in advancing biotech and healthcare innovation. The discussion featured senior ARPA-H leaders and explored how government and industry can work together to accelerate breakthrough science and real-world impact.
Read More about WBB Securities President Dr. Steve Brozak to Moderate ARPA-H Panel at Biotech Showcase 2026 on Federal Investment in Biotech InnovationWBB Securities, LLC has initiated research coverage of Turn Therapeutics, Inc. (NasdaqCM: TTRX), a clinical-stage biotechnology company focused on developing therapies for inflammatory skin and infectious diseases.
Read More about WBB Securities Initiates Coverage of Turn Therapeutics (Nasdaq: TTRX)